The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with (±)-11C-YJH08 PET. Read more about The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with (±)-11C-YJH08 PET.
A Conversation Between Joseph Osborne and Thomas Hope. Read more about A Conversation Between Joseph Osborne and Thomas Hope.
Nuclear Imaging of Bacterial Infection: The State of the Art and Future Directions. Read more about Nuclear Imaging of Bacterial Infection: The State of the Art and Future Directions.
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? Read more about Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors. Read more about Intraarterial Peptide Receptor Radionuclide Therapy Using 90Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.
The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging. Read more about The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging.
124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma. Read more about 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.
Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial. Read more about Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer. Read more about Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer.
Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment. Read more about Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment.
